Clinical Trials Browser

Terminated × OTHER × cemiplimab × Clear all

NCT04729725 2023-08-14

SAR439459 and Cemiplimab for the Treatment of Advanced or Unresectable Solid Tumors, Strategic Alliance, TACTIC TRIAL

Phase 1 Terminated

Neoplasm Metastasis